Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00000343 · ClinicalTrials.gov registry record · Phase 4

Brain Changes in Stimulant Dependent Subjects - 8

A Phase 4 study, sponsored by National Institute on Drug Abuse (NIDA).

Completed
Registry status
Phase 4
Development phase
90
Enrollment target

NCT00000343: Completed Phase 4 study, sponsored by National Institute on Drug Abuse (NIDA).

NCT00000343 is a Phase 4 study that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 90 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00000343, a Phase 4 study, has completed, sponsored by National Institute on Drug Abuse (NIDA).

COMPLETED
Registry status
Phase 4
Development phase
90 participants
Enrollment target

Study Summary

The purpose of this study is to identify the neurophysiologic indicators of cocaine or methamphetamine use and withdrawal, to examine the relationship between subjects' reports of depression, craving, and stimulant use, and neurophysiologic measures, and to identify neurophysiologic measures which can be used to identify new treatments for stimulant dependence.

Interventions

  • BEHAVIORAL counseling

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 1996-04
Phase Phase 4

What the finished NCT00000343 record still lists

NCT00000343 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (83% lower).

The record links to 0 conditions, and to 1 intervention - of which counseling is the first listed.

NCT00000343 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00000343 about?

NCT00000343 is a clinical study titled "Brain Changes in Stimulant Dependent Subjects - 8". The purpose of this study is to identify the neurophysiologic indicators of cocaine or methamphetamine use and withdrawal, to examine the relationship between subjects' reports of depression, craving, and stimulant use, and neurophysiologic measures, and to identify neurophysiologic measures which c...

What is the current status of trial NCT00000343?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 90 participants. The study started on 1996-04.

What interventions are being tested in trial NCT00000343?

The interventions under investigation include: counseling (BEHAVIORAL).

Who is sponsoring clinical trial NCT00000343?

This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00000343's enrollment target sits among peer trials

90 886th of 2000 higher than 1,088 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02521311 · 90 participants · Phase 2

    Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)

  • NCT02939573 · 90 participants · Phase 2

    A Randomized Multicenter Study for Isolated Skin Vasculitis

  • NCT03128879 · 90 participants · Phase 2

    Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL

  • NCT03184038 · 90 participants · NA

    Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00000343, the US trial registry maintained by the National Library of Medicine. NCT00000343 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.